| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lonneke J van Nimwegen, Lieuwe de Haan, Nico Jm van Beveren, Mischa van der Helm, Wim van den Brink, Don Linsze. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 53. issue 6. 2008-09-17. PMID:18616861. |
effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. |
2008-09-17 |
2023-08-12 |
Not clear |
| Lonneke J van Nimwegen, Lieuwe de Haan, Nico Jm van Beveren, Mischa van der Helm, Wim van den Brink, Don Linsze. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 53. issue 6. 2008-09-17. PMID:18616861. |
to examine whether subjective well-being and craving for cannabis were different in patients with schizophrenia or related disorders treated with either olanzapine or risperidone. |
2008-09-17 |
2023-08-12 |
Not clear |
| P-M Llorca, P Bouhours, V Moreau-Malle. Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone. L'Encephale. vol 34. issue 2. 2008-09-09. PMID:18597725. |
to investigate the efficacy and tolerability of direct initiation of long-acting injectable risperidone (lair) in adults with schizophrenia or other psychotic disorders requiring a change of treatment. |
2008-09-09 |
2023-08-12 |
Not clear |
| Lawrence Blonde, Hong J Kan, Elane M Gutterman, Gilbert J L'Italien, Myoung S Kim, Linda Hanssens, Robert D McQuad. Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care. The Journal of clinical psychiatry. vol 69. issue 5. 2008-09-03. PMID:18435564. |
in clinical trials, effects on metabolic parameters with aripiprazole are similar to those with placebo and superior to those with olanzapine, and the schizophrenia trial of aripiprazole (star) demonstrated comparable efficacy of aripiprazole versus standard of care (soc; physicians' selection of quetiapine, olanzapine, or risperidone). |
2008-09-03 |
2023-08-12 |
Not clear |
| S Kristian Hill, James L Reilly, Margret S H Harris, Tin Khine, John A Sweene. Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia. Schizophrenia bulletin. vol 34. issue 3. 2008-08-12. PMID:17932088. |
antipsychotic-naive patients with schizophrenia were tested before treatment with risperidone and again 6 weeks later. |
2008-08-12 |
2023-08-12 |
human |
| Richard S E Keefe, Anil K Malhotra, Herbert Y Meltzer, John M Kane, Robert W Buchanan, Anita Murthy, Mindy Sovel, Chunming Li, Robert Goldma. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 33. issue 6. 2008-08-07. PMID:17625502. |
in total, 250 patients (18-55 years) with schizophrenia or schizoaffective disorder who were clinically stabilized on risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole, alone or in combination, were enrolled at 38 outpatient psychiatric clinics in the united states. |
2008-08-07 |
2023-08-12 |
Not clear |
| Matthew J Byerly, Paul A Nakonezny, A John Rus. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. Psychiatry research. vol 159. issue 1-2. 2008-07-25. PMID:18295343. |
sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. |
2008-07-25 |
2023-08-12 |
Not clear |
| Matthew J Byerly, Paul A Nakonezny, A John Rus. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. Psychiatry research. vol 159. issue 1-2. 2008-07-25. PMID:18295343. |
outpatients (n=42, age>or=18 years) with schizophrenia or schizoaffective disorder who experienced risperidone-associated sexual dysfunction were randomized to 6 weeks of double-blind risperidone continuation (mean dose=4.1 mg/day, s.d.=1.2) or quetiapine switch (mean dose=290.0 mg/day, s.d.=55.2) treatment. |
2008-07-25 |
2023-08-12 |
Not clear |
| Chun-Hsin Chen, Chih-Chiang Chiu, Ming-Chyi Huang, Tzu-Hua Wu, Hui-Ching Liu, Mong-Liang L. Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 4. 2008-07-22. PMID:18082302. |
the second generation antipsychotic drugs, such as risperidone, olanzapine, and quetiapine, are effective in treating patients with schizophrenia and have been considered as the first line therapy. |
2008-07-22 |
2023-08-12 |
human |
| Jin Hun Kim, Daeho Kim, Stephen R Marde. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 4. 2008-07-22. PMID:18262321. |
time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. |
2008-07-22 |
2023-08-12 |
Not clear |
| Jin Hun Kim, Daeho Kim, Stephen R Marde. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 4. 2008-07-22. PMID:18262321. |
in this prospective, naturalistic, observational, community-survival-analysis study, we compared the effect of clozapine and risperidone on two-year psychiatric hospitalization rate and time to hospitalization in the treatment of patients with schizophrenia and comorbid aud. |
2008-07-22 |
2023-08-12 |
Not clear |
| Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, Bruce J Kino. Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia. Current medical research and opinion. vol 24. issue 5. 2008-07-22. PMID:18397549. |
switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia. |
2008-07-22 |
2023-08-12 |
Not clear |
| Douglas E Faries, Haya Ascher-Svanum, Allen W Nyhuis, Bruce J Kino. Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia. Current medical research and opinion. vol 24. issue 5. 2008-07-22. PMID:18397549. |
this study examines the effectiveness of olanzapine therapy following a clinically warranted switch from risperidone during treatment of patients with schizophrenia. |
2008-07-22 |
2023-08-12 |
Not clear |
| Zekai Halici, Osman Nuri Keles, Deniz Unal, Mevlut Albayrak, Halis Suleyman, Elif Cadirci, Bunyami Unal, Suleyman Kapla. Chronically administered risperidone did not change the number of hepatocytes in rats: a stereological and histopathological study. Basic & clinical pharmacology & toxicology. vol 102. issue 5. 2008-07-17. PMID:18248514. |
risperidone, an antipsychotic agent, has been used in the therapy of patients with acute and chronic schizophrenia. |
2008-07-17 |
2023-08-12 |
rat |
| S Kristian Hill, John A Sweeney, Robert M Hamer, Richard S E Keefe, Diana O Perkins, Hongbin Gu, Joseph P McEvoy, Jeffrey A Lieberma. Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia. Journal of the International Neuropsychological Society : JINS. vol 14. issue 2. 2008-07-15. PMID:18282319. |
participants were primarily first episode schizophrenia patients who completed baseline (n = 367) and 12-week (n = 219) assessments with the bacs (brief assessment of cognition in schizophrenia) and catie (clinical antipsychotic trials of intervention effectiveness) neuropsychological batteries in a clinical trial comparing olanzapine, quetiapine, and risperidone. |
2008-07-15 |
2023-08-12 |
human |
| F Limosin, J M Azorin, M O Krebs, B Millet, J Glikman, V Camus, M A Crocq, J Costentin, J Dalér. [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia]. L'Encephale. vol 34. issue 1. 2008-07-15. PMID:18514155. |
five short-term efficacy studies, conducted on 1648 patients presenting with schizophrenia or acute relapse of schizoaffective disorders, demonstrated the greater efficacy of aripiprazole than the placebo and comparable efficacy to that of haloperidol and risperidone. |
2008-07-15 |
2023-08-12 |
Not clear |
| Samarand Salimi, Akbar Fotouhi, Abolfazl Ghoreishi, Mohammad-Kamran Derakhshan, Mohammad-Reza Khodaie-Ardakani, Mohammad-Reza Mohammadi, Ahmad-Ali Noorbala, Seyed-Ali Ahmadi-Abhari, Mohammad Hajiazim, Seyed-Hesameddin Abbasi, Shahin Akhondzade. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 3. 2008-07-02. PMID:18096287. |
a placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. |
2008-07-02 |
2023-08-12 |
human |
| Victor Perez, Fernando Cañas, Monica Tafall. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. International clinical psychopharmacology. vol 23. issue 3. 2008-06-26. PMID:18408528. |
a 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. |
2008-06-26 |
2023-08-12 |
Not clear |
| Victor Perez, Fernando Cañas, Monica Tafall. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. International clinical psychopharmacology. vol 23. issue 3. 2008-06-26. PMID:18408528. |
this multicentre, observational, prospective, nonrandomized study compared the effectiveness and tolerability of quetiapine and risperidone in the acute and long-term treatment of schizophrenia in a clinical setting. |
2008-06-26 |
2023-08-12 |
Not clear |
| Sophie Rémillard, Emmanuelle Pourcher, Henri Cohe. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. Journal of the International Neuropsychological Society : JINS. vol 14. issue 1. 2008-06-20. PMID:18078537. |
long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. |
2008-06-20 |
2023-08-12 |
human |